Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 30 | 30 | 4 |
| Full Text Views | 316 | 57 | 1 |
| PDF Downloads | 59 | 10 | 3 |
Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection.
Norihiro Furusyo
Norihiro Furusyo
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Norihiro Furusyo in
Current site
Google Scholar
PubMed
Search for other papers by Norihiro Furusyo in
Current site
Google Scholar
PubMed
Hisashi Nakashima
Hisashi Nakashima
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Hisashi Nakashima in
Current site
Google Scholar
PubMed
Search for other papers by Hisashi Nakashima in
Current site
Google Scholar
PubMed
Kenichiro Kashiwagi
Kenichiro Kashiwagi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Kenichiro Kashiwagi in
Current site
Google Scholar
PubMed
Search for other papers by Kenichiro Kashiwagi in
Current site
Google Scholar
PubMed
Norihiko Kubo
Norihiko Kubo
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Norihiko Kubo in
Current site
Google Scholar
PubMed
Search for other papers by Norihiko Kubo in
Current site
Google Scholar
PubMed
Kazuhiro Hayashida
Kazuhiro Hayashida
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Kazuhiro Hayashida in
Current site
Google Scholar
PubMed
Search for other papers by Kazuhiro Hayashida in
Current site
Google Scholar
PubMed
Sadakazu Usuda
Sadakazu Usuda
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Sadakazu Usuda in
Current site
Google Scholar
PubMed
Search for other papers by Sadakazu Usuda in
Current site
Google Scholar
PubMed
Shunji Mishiro
Shunji Mishiro
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Shunji Mishiro in
Current site
Google Scholar
PubMed
Search for other papers by Shunji Mishiro in
Current site
Google Scholar
PubMed
Seizaburo Kashiwagi
Seizaburo Kashiwagi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Seizaburo Kashiwagi in
Current site
Google Scholar
PubMed
Search for other papers by Seizaburo Kashiwagi in
Current site
Google Scholar
PubMed
Jun Hayashi
Jun Hayashi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan. furusyo@genmedpr.med.kyushu-u.ac.jp
Search for other papers by Jun Hayashi in
Current site
Google Scholar
PubMed
Search for other papers by Jun Hayashi in
Current site
Google Scholar
PubMed
The aims of this retrospective survey were to determine the epidemiologic distribution of hepatitis B virus (HBV) genotypes and analyze the genotype-related clinical differences among Japanese patients with chronic HBV infection. The 158 surveyed patients with chronic HBV infection lived in Fukuoka and Okinawa were serially tested for serum alanine aminotransferase (ALT) and hepatitis B e antigen (HBeAg). Follow-up was for a period of 10.8 +/- 6.4 years (mean +/- SD). The HBV genotypes were determined in sera by an enzyme-linked immunosorbent assay and detection of HBV DNA in serum was done by the transcription-mediated amplification-hybridization protection assay. Genotypes B and C were found in 58 (36.7%) and 100 (63.3%) of the patients, respectively. Genotype B was predominant in Okinawa (B = 86.9%, C = 13.1%), whereas genotype C was predominant in Fukuoka (B = 5.2%, C = 94.8%). The HBeAg positivity and ALT abnormality rates at the start of the observation period were significantly higher in patients with genotype C (66.0% and 84.0%) than in patients with genotype B (34.5% and 22.4%) (P < 0.05, respectively). The annual rate of spontaneous HBeAg disappearance in patients with genotype B was much higher than in patients with genotype C (8.38% versus 2.34%, respectively). Patients with genotype C who were continuously HBeAg negative from entry had a significantly higher ALT abnormality (58.8%) than those with genotype B (19.2%) (P < 0.05). Interestingly, patients with genotype C who became HBeAg negative after treatment with interferon had a high ALT abnormality (58.8%). All patients with an ALT abnormality were positive for HBV DNA in their serum. These findings indicate that patients with HBV genotype C have more severe liver deterioration because of the delay of HBeAg disappearance and continued HBV replication after HBeAg disappearance.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 30 | 30 | 4 |
| Full Text Views | 316 | 57 | 1 |
| PDF Downloads | 59 | 10 | 3 |